{'52WeekChange': 0.96000004,
 'SandP52WeekChange': 0.0644362,
 'address1': '101 Poor Farm Road',
 'algorithm': None,
 'annualHoldingsTurnover': None,
 'annualReportExpenseRatio': None,
 'ask': 2.46,
 'askSize': 3000,
 'averageDailyVolume10Day': 832475,
 'averageVolume': 2141236,
 'averageVolume10days': 832475,
 'beta': 1.470588,
 'beta3Year': None,
 'bid': 2.43,
 'bidSize': 2900,
 'bookValue': 1.039,
 'category': None,
 'circulatingSupply': None,
 'city': 'Princeton',
 'companyOfficers': [],
 'country': 'United States',
 'currency': 'USD',
 'dateShortInterest': 1593475200,
 'dayHigh': 2.515,
 'dayLow': 2.435,
 'dividendRate': None,
 'dividendYield': None,
 'earningsQuarterlyGrowth': None,
 'enterpriseToEbitda': -6.265,
 'enterpriseToRevenue': None,
 'enterpriseValue': 135347376,
 'exDividendDate': None,
 'exchange': 'NMS',
 'exchangeTimezoneName': 'America/New_York',
 'exchangeTimezoneShortName': 'EDT',
 'expireDate': None,
 'fiftyDayAverage': 2.7144287,
 'fiftyTwoWeekHigh': 4.765,
 'fiftyTwoWeekLow': 0.35,
 'fiveYearAverageReturn': None,
 'fiveYearAvgDividendYield': None,
 'floatShares': 65502355,
 'forwardEps': -0.31,
 'forwardPE': -7.903226,
 'fromCurrency': None,
 'fullTimeEmployees': 15,
 'fundFamily': None,
 'fundInceptionDate': None,
 'gmtOffSetMilliseconds': '-14400000',
 'heldPercentInsiders': 0.0069,
 'heldPercentInstitutions': 0.3886,
 'industry': 'Drug Manufacturers—Specialty & Generic',
 'isEsgPopulated': False,
 'lastCapGain': None,
 'lastDividendValue': None,
 'lastFiscalYearEnd': 1577750400,
 'lastMarket': None,
 'lastSplitDate': None,
 'lastSplitFactor': None,
 'legalType': None,
 'logo_url': 'https://logo.clearbit.com/agiletherapeutics.com',
 'longBusinessSummary': "Agile Therapeutics, Inc., a women's healthcare "
                        'company, focuses on the research, development, and '
                        'commercialization of prescription contraceptive '
                        'products for women. Its lead product candidate is '
                        'Twirla, also known as AG200-15, a once-weekly '
                        'prescription contraceptive patch. The company is also '
                        'developing a pipeline of Twirla line extensions and '
                        'other transdermal contraceptive products, including '
                        'AG200-ER, a regimen that allows a woman to extend the '
                        'length of her cycle; AG200-SP, which is a regimen '
                        'designed to provide shorter and lighter periods; '
                        'AG200-ER (SmP), a regimen to allow a woman to extend '
                        'the length of her cycle, as well as experience '
                        'shorter and lighter periods; and AG890, a '
                        'progestin-only contraceptive patch intended for use '
                        'by women who are unable or unwilling to take '
                        'estrogen. Agile Therapeutics, Inc. was founded in '
                        '1997 and is headquartered in Princeton, New Jersey.',
 'longName': 'Agile Therapeutics, Inc.',
 'market': 'us_market',
 'marketCap': 213672352,
 'maxAge': 1,
 'maxSupply': None,
 'messageBoardId': 'finmb_858721',
 'morningStarOverallRating': None,
 'morningStarRiskRating': None,
 'mostRecentQuarter': 1585612800,
 'navPrice': None,
 'netIncomeToCommon': -21820000,
 'nextFiscalYearEnd': 1640908800,
 'open': 2.48,
 'openInterest': None,
 'payoutRatio': 0,
 'pegRatio': None,
 'phone': '609 683 1880',
 'previousClose': 2.52,
 'priceHint': 4,
 'priceToBook': 2.3580365,
 'priceToSalesTrailing12Months': None,
 'profitMargins': 0,
 'quoteType': 'EQUITY',
 'regularMarketDayHigh': 2.515,
 'regularMarketDayLow': 2.435,
 'regularMarketOpen': 2.48,
 'regularMarketPreviousClose': 2.52,
 'regularMarketPrice': 2.48,
 'regularMarketVolume': 697063,
 'revenueQuarterlyGrowth': None,
 'sector': 'Healthcare',
 'sharesOutstanding': 87213200,
 'sharesPercentSharesOut': 0.0538,
 'sharesShort': 4690883,
 'sharesShortPreviousMonthDate': 1590710400,
 'sharesShortPriorMonth': 2872770,
 'shortName': 'Agile Therapeutics, Inc.',
 'shortPercentOfFloat': 0.066300005,
 'shortRatio': 2.02,
 'startDate': None,
 'state': 'NJ',
 'strikePrice': None,
 'symbol': 'AGRX',
 'threeYearAverageReturn': None,
 'toCurrency': None,
 'totalAssets': None,
 'tradeable': False,
 'trailingAnnualDividendRate': None,
 'trailingAnnualDividendYield': None,
 'trailingEps': -0.368,
 'twoHundredDayAverage': 2.7104676,
 'volume': 697063,
 'volume24Hr': None,
 'volumeAllCurrencies': None,
 'website': 'http://www.agiletherapeutics.com',
 'yield': None,
 'ytdReturn': None,
 'zip': '08540'}